These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 28902320)

  • 21. Investing in nutrition at the national level: an African perspective.
    Kavishe FP
    Proc Nutr Soc; 1995 Jul; 54(2):367-78. PubMed ID: 8524884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Perspectives on financing population-based health care towards Universal Health Coverage among employed individuals in Ghanzi district, Botswana: A qualitative study".
    Mbogo BA; McGill D
    BMC Health Serv Res; 2016 Aug; 16(1):413. PubMed ID: 27543136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income countries.
    Schäferhoff M; Zimmerman A; Diab MM; Mao W; Chowdhary V; Gill D; Karanja R; Madikizela M; Ogbuoji O; Yamey G
    Lancet Glob Health; 2022 Jul; 10(7):e1045-e1052. PubMed ID: 35714631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What level of domestic government health expenditure should we aspire to for universal health coverage?
    Mcintyre D; Meheus F; Røttingen JA
    Health Econ Policy Law; 2017 Apr; 12(2):125-137. PubMed ID: 28332456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Institutional obstacles to expansion of world food production.
    Crosson PR
    Science; 1975 May; 188(4188):519-24. PubMed ID: 17740002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review.
    Ozawa S; Mirelman A; Stack ML; Walker DG; Levine OS
    Vaccine; 2012 Dec; 31(1):96-108. PubMed ID: 23142307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evolution and new perspectives of health care financing in developing countries].
    Audibert M; Mathonnat J; de Roodenbeke E
    Sante; 2003; 13(4):209-14. PubMed ID: 15047437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hong Kong domestic health spending: financial years 1989/90 to 2011/12.
    Tin KY; Tsoi PK; Lee YH; Chong DS; Lam DW; Yeung AY; Ma ES; Maw CK
    Hong Kong Med J; 2015 Jun; 21(3 Suppl 3):1-24. PubMed ID: 26045183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-benefit comparisons of investments in improved water supply and cholera vaccination programs.
    Jeuland M; Whittington D
    Vaccine; 2009 May; 27(23):3109-20. PubMed ID: 19428925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Public financing of health in developing countries: a cross-national systematic analysis.
    Lu C; Schneider MT; Gubbins P; Leach-Kemon K; Jamison D; Murray CJ
    Lancet; 2010 Apr; 375(9723):1375-87. PubMed ID: 20381856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries.
    NCD Countdown 2030 collaborators
    Lancet; 2022 Mar; 399(10331):1266-1278. PubMed ID: 35339227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The social value of investing in public health across the life course: a systematic scoping review.
    Ashton K; Schröder-Bäck P; Clemens T; Dyakova M; Stielke A; Bellis MA
    BMC Public Health; 2020 May; 20(1):597. PubMed ID: 32357876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Child health and nutrition in Peru within an antipoverty political agenda: a Countdown to 2015 country case study.
    Huicho L; Segura ER; Huayanay-Espinoza CA; de Guzman JN; Restrepo-Méndez MC; Tam Y; Barros AJ; Victora CG;
    Lancet Glob Health; 2016 Jun; 4(6):e414-26. PubMed ID: 27198845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investing in non-communicable diseases: an estimation of the return on investment for prevention and treatment services.
    Bertram MY; Sweeny K; Lauer JA; Chisholm D; Sheehan P; Rasmussen B; Upreti SR; Dixit LP; George K; Deane S
    Lancet; 2018 May; 391(10134):2071-2078. PubMed ID: 29627159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the business community: investing in human potential.
    Salus; 1992 Jul; 15(3):20-1. PubMed ID: 12179905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Universal health coverage in 'One ASEAN': are migrants included?
    Guinto RL; Curran UZ; Suphanchaimat R; Pocock NS
    Glob Health Action; 2015; 8():25749. PubMed ID: 25626624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Financing the HIV response in sub-Saharan Africa from domestic sources: Moving beyond a normative approach.
    Remme M; Siapka M; Sterck O; Ncube M; Watts C; Vassall A
    Soc Sci Med; 2016 Nov; 169():66-76. PubMed ID: 27693973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economics and health: beyond financing.
    Horwitz A
    Bull Pan Am Health Organ; 1988; 22(4):430-9. PubMed ID: 3242741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of health promotion and prevention financing mechanisms in Thailand.
    Watabe A; Wongwatanakul W; Thamarangsi T; Prakongsai P; Yuasa M
    Health Promot Int; 2017 Aug; 32(4):702-710. PubMed ID: 26989011
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.